Specifically, while MEFV and STAT3 expression was detected in both glioblastoma cells and immune cells, SARM1 expression level was higher in NPC-like and OPC-like glioblastoma cells than in MES-like, AC-like glioblastoma cells, and other tumor cells (Figure 7D–G). This evidence concerns the gene SARM1 and glioblastoma.